ZA796896B - Pharmaceutical composition having antitumor activity - Google Patents

Pharmaceutical composition having antitumor activity

Info

Publication number
ZA796896B
ZA796896B ZA00796896A ZA796896A ZA796896B ZA 796896 B ZA796896 B ZA 796896B ZA 00796896 A ZA00796896 A ZA 00796896A ZA 796896 A ZA796896 A ZA 796896A ZA 796896 B ZA796896 B ZA 796896B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
antitumor activity
antitumor
activity
pharmaceutical
Prior art date
Application number
ZA00796896A
Other languages
English (en)
Inventor
M Fujii
T Fujii
K Matsunaga
C Yoshikumi
K Niimura
Y Oguchi
Original Assignee
Kureha Chemical Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Chemical Ind Co Ltd filed Critical Kureha Chemical Ind Co Ltd
Publication of ZA796896B publication Critical patent/ZA796896B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812Peptides or proteins is immobilized on, or in, an organic carrier
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/813Carrier is a saccharide

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA00796896A 1978-12-29 1979-12-19 Pharmaceutical composition having antitumor activity ZA796896B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16138878A JPS5592325A (en) 1978-12-29 1978-12-29 Antitumor agent and its preparation

Publications (1)

Publication Number Publication Date
ZA796896B true ZA796896B (en) 1980-11-26

Family

ID=15734135

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00796896A ZA796896B (en) 1978-12-29 1979-12-19 Pharmaceutical composition having antitumor activity

Country Status (4)

Country Link
JP (1) JPS5592325A (xx)
AU (1) AU518952B2 (xx)
BE (1) BE880970A (xx)
ZA (1) ZA796896B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5665828A (en) * 1979-11-02 1981-06-03 Kureha Chem Ind Co Ltd Antitumor agent
JPS58118520A (ja) * 1982-01-09 1983-07-14 Hidematsu Hirai 抗腫瘍性蛋白複合体およびその製造法
US4448663A (en) * 1982-07-06 1984-05-15 The Dow Chemical Company Double L-shaped electrode for brine electrolysis cell
JPH0651643B2 (ja) * 1983-01-19 1994-07-06 帝人株式会社 殺細胞性修飾免疫グロブリン及びその製造方法
JPH0611713B2 (ja) * 1983-04-08 1994-02-16 呉羽化学工業株式会社 ヒト免疫グロブリン結合抗腫瘍剤
JPS6041617A (ja) * 1983-08-18 1985-03-05 Teijin Ltd 殺細胞性修飾免疫グロブリン及びその製造法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS162953B1 (xx) * 1972-05-10 1975-07-31
GB1509707A (en) * 1974-09-20 1978-05-04 Searle & Co Immunological compounds
IL47372A (en) * 1975-05-27 1979-10-31 Yeda Res & Dev Fab'dimers bound to daunomycin or adriamycin,their preparation and pharmaceutical compositions containing same

Also Published As

Publication number Publication date
AU518952B2 (en) 1981-10-29
JPS6254086B2 (xx) 1987-11-13
JPS5592325A (en) 1980-07-12
AU5414479A (en) 1980-07-03
BE880970A (fr) 1980-06-30

Similar Documents

Publication Publication Date Title
PH16902A (en) Pharmaceutical composition having anti-tumor activity
GB2039738B (en) Inflammation - preventing pharmaceutical composition
JPS52114026A (en) Pharmaceutical composition having antiiinflammation activity
JPS53113007A (en) Pharmaceutical composition
JPS53109934A (en) Pharmaceutical composition
JPS54132223A (en) Novel pharmaceutical composition
GB2003028B (en) Pharmaceutical compositions
JPS5484022A (en) Pharmaceutical composition
JPS53133637A (en) Pharmaceutical composition
JPS5449333A (en) Pharmaceutical composition
PH15193A (en) Pharmaceutical composition
IL56577A0 (en) Pharmaceutical compositions comprising certain pyrrolidinederivatives
GB2021409B (en) Pharmaceutical composition
GB2002229B (en) Pharmaceutical composition
JPS5394038A (en) Pharmaceutical composition
GB2034587B (en) Pharmaceutical compositions
ZA796896B (en) Pharmaceutical composition having antitumor activity
IL54220A0 (en) Pharmaceutical compositions comprising trans-broparestrol
GB2039218B (en) Pharmaceutical compositions
GB2031727B (en) Pharmaceutical compositions
JPS54154516A (en) Pharmaceutical composition
JPS53101520A (en) Pharmaceutical composition
JPS5527168A (en) Drug composition
JPS5386039A (en) Pharmaceutical composition having antiitumor activity
JPS545045A (en) Pharmaceutical composition